Table 3.
Summary statistics of semen parameters, SDF, and ORP before and after the treatment with FH PRO for Men in idiopathic infertile patients having high ORP levels.
| Parameters | Before Treatment | n | After Treatment | n | Percent Change (Mean ± SEM) |
p Value Wilcoxon Test |
|---|---|---|---|---|---|---|
| Sperm concentration (106/mL) | 14.1 ± 15.6 (10.0; 3.1–19.0) |
108 | 23.1 ± 22.9 (14.0; 5.4–38.0) |
108 | 151.30 ± 39.3 | <0.0001 |
| Total motility (%) | 30.2 ± 16.6 (30.0; 17.5–42.5) |
108 | 34.9 ± 19.4 (40.0; 15.0–50.0) |
108 | 51.3 ± 15.3 | 0.0043 |
| Progressive motility (%) | 2.5 ± 5.7 (0.0; 0.0–0.0) |
108 | 5.7 ± 7.9 (0.0; 0.0–10.0) |
108 | 28.9 ± 7.2 | 0.0002 |
| Normal morphology (%) | 2.2 ± 1.7 (2.0; 1.0–3.0) |
108 | 4.1 ± 9.7 (3.0; 1.0–4.5) |
108 | 92.1 ± 23.3 | <0.0001 |
| SDF (%) | 43.0 ± 21.9 (42.5; 25.0–61.5) |
67 | 37.1 ± 19.8 (30.0; 22.0–44.3) |
67 | −1.4 ± 7.2 | 0.0105 |
| ORP (mV/106 sperm/mL) | 13.5 ± 17.2 (6.5; 3.6–14.5) |
108 | 8.0 ± 16.4 (2.5; 1.1–8.6) |
108 | −27.3 ± 11.9 | <0.0001 |
ORP ≥ 1.34 mV/106 sperm/mL is considered as high. SDF: sperm DNA fragmentation, ORP: oxidation-reduction potential.